Home/Filings/4/0001104659-20-060887
4//SEC Filing

Ahmed Mahiuddin 4

Accession 0001104659-20-060887

CIK 0001722964other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 4:30 PM ET

Size

4.9 KB

Accession

0001104659-20-060887

Insider Transaction Report

Form 4
Period: 2020-05-12
Ahmed Mahiuddin
Sr. VP & Chief Scientific Off
Transactions
  • Sale

    Common Stock

    2020-05-12$39.19/sh20,000$783,776240,000 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $ 39.5500 to $ 38.2300. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Y-mAbs Therapeutics, Inc.

CIK 0001722964

Entity typeother

Related Parties

1
  • filerCIK 0001799304

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:30 PM ET
Size
4.9 KB